BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27130457)

  • 1. Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population.
    Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
    Lung; 2016 Jun; 194(3):393-400. PubMed ID: 27130457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of the stem cell marker gene
    Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
    BMJ Open; 2017 Aug; 7(8):e016913. PubMed ID: 28827262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer.
    Wang Q; Liu H; Xiong H; Liu Z; Wang LE; Qian J; Muddasani R; Lu V; Tan D; Ajani JA; Wei Q
    Mol Carcinog; 2015 Jun; 54(6):449-58. PubMed ID: 24302553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.
    Jia ZF; Wu YH; Cao DH; Cao XY; Jiang J; Zhou BS
    Future Oncol; 2017 May; 13(11):979-989. PubMed ID: 28326835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of CD133 polymorphisms on the risk of developing liver cirrhosis and hepatocellular carcinoma induced by viral hepatitis.
    Hassan M; Nasr SM; Elzallat M
    Virus Res; 2022 Apr; 312():198714. PubMed ID: 35181408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Combination of CD44 rs187116, CD133 rs2240688, NF-κB1 rs28362491 and GSTM1 Deletion as a Potential Biomarker in Risk Prediction of Breast Cancer in Lower Northern Thailand.
    Sapcharoen K; Sanguansermsri P; Yasothornsrikul S; Muisuk K; Srikummool M
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2493-2502. PubMed ID: 31450925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.
    Sun J; Zhu M; Shen W; Wang C; Dai J; Xu L; Jin G; Hu Z; Ma H; Shen H
    Pharmacogenomics J; 2017 Jun; 17(3):280-285. PubMed ID: 26951883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
    Chae MH; Jang JS; Kang HG; Park JH; Park JM; Lee WK; Kam S; Lee EB; Son JW; Park JY
    Mol Carcinog; 2006 Apr; 45(4):239-49. PubMed ID: 16385589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contribution of
    Chen GL; Shen TC; Chang WS; Tsai CW; Li HT; Chuang CL; Lai YL; Yueh TC; Hsia TC; Wang SC; Bau DT
    Anticancer Res; 2018 Oct; 38(10):5671-5677. PubMed ID: 30275186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression.
    Cheng M; Yang L; Yang R; Yang X; Deng J; Yu B; Huang D; Zhang S; Wang H; Qiu F; Zhou Y; Lu J
    Carcinogenesis; 2013 Oct; 34(10):2292-9. PubMed ID: 23715500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tagging single nucleotide polymorphisms in MBD4 are associated with risk of lung cancer in a Chinese population.
    Miao R; Gu H; Liu H; Hu Z; Jin G; Wang H; Wang Y; Sun W; Ma H; Chen D; Tian T; Jin L; Wei Q; Lu D; Huang W; Shen H
    Lung Cancer; 2008 Dec; 62(3):281-6. PubMed ID: 18495292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer.
    Wang X; Hu JF; Tan Y; Cui J; Wang G; Mrsny RJ; Li W
    PLoS One; 2014; 9(5):e95915. PubMed ID: 24787949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNP rs2240688 in
    Pan X; Huang L; Mo D; Liang Y; Huang Z; Zhu B; Fang M
    Transl Cancer Res; 2020 Oct; 9(10):5940-5948. PubMed ID: 35117206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population.
    Niu X; Chen Z; Shen S; Liu Y; Zhou D; Zhang J; Li Z; Yu Y; Liao M; Lu S; He L
    J Thorac Oncol; 2010 May; 5(5):658-66. PubMed ID: 20234319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Polymorphisms in the Apoptosis-Associated Gene CASP3 and the Risk of Lung Cancer in Chinese Population.
    Lin J; Zhang Y; Wang H; Chang J; Wei L; Cao L; Zhang Z; Zhang X
    PLoS One; 2016; 11(10):e0164358. PubMed ID: 27723786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers.
    Zhang Y; Hua S; Zhang A; Kong X; Jiang C; Deng D; Wenlong B
    Clin Lung Cancer; 2013 Jan; 14(1):45-9. PubMed ID: 22658813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glu346Lys polymorphism in the methyl-CpG binding domain 4 gene and the risk of primary lung cancer.
    Shin MC; Lee SJ; Choi JE; Cha SI; Kim CH; Lee WK; Kam S; Kang YM; Jung TH; Park JY
    Jpn J Clin Oncol; 2006 Aug; 36(8):483-8. PubMed ID: 16803845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer.
    Kuo WH; Shih CM; Lin CW; Cheng WE; Chen SC; Chen W; Lee YL
    Transl Res; 2012 Jan; 159(1):42-50. PubMed ID: 22153809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type.
    Okasaka T; Matsuo K; Suzuki T; Ito H; Hosono S; Kawase T; Watanabe M; Yatabe Y; Hida T; Mitsudomi T; Tanaka H; Yokoi K; Tajima K
    J Hum Genet; 2009 Dec; 54(12):739-45. PubMed ID: 19881468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.